首页> 外文会议>World biomaterials congress >BIOWIRE: Tissue culture and drug screening platform using high fidelity 3D engineered cardiac tissue
【24h】

BIOWIRE: Tissue culture and drug screening platform using high fidelity 3D engineered cardiac tissue

机译:BIOWIRE:使用高保真3D工程心脏组织的组织培养和药物筛选平台

获取原文

摘要

An average of $1.5 billion is spent trying to bring a new drug to the market, while a large portion of these drugs is withdrawn at the later stage of the development. Up to 20% of recent drug withdrawals were due to cardiac toxicity and proarrhythmic effects. 3D tissue constructs possess better physiological relevance and therefore provide more reliable toxicology responses comparing to conventional 2D tissue Thus, 3D tissue-specific toxicity screening with a human cardiac model should be used to weed out the unqualified drug candidates in a high throughput manner. The platform in this research enables batch production of 3D human cardiac tissues and can provide accurate force readouts as key reference for toxicity evaluation. The platform also incorporates array of electrodes to provide field stimulation of progressive frequency increase, which can significantly mature tissue to an infant-like state. The entire platform is made of polystyrene which provide a drug- inert environment to eliminate the drug absorption problem caused by polydimethylsiloxane (PDMS). Hot embossing technique with polystyrene will generate micro-wells with dimension of 5mm by 1 mm by 300mm, which will fit in a single well of a 96 well-plate. Every micro-well will have two auto-fluorescent and flexible wires made of poly(octamethylene maleate (anhydride) citrate) positioned at the edges of the well. After cell seeding, cardiac tissue will compact around wires and hang in the well. Gold printed electrodes will be located at both ends of the well and connected with electrical stimulators (Grass88X). Optical and fluorescence high speed camera will record shape changes of the wires over time during tissue contraction in the device. By tracking the deflection of the wire, beam deflection equation will be used to measure tissue generated contractive forces. Beating frequency, amplitude, contraction and relaxation times will be easily acquired as well. The accuracy of the device will be validated by comparing the calculated forces and the ones measured using a force transducer. This device can eliminate the common drawback of post deflection design, in which tissue often slips off the posts. The design will also prevent inconveniently measuring positions of tissue on posts, which is a crucial parameter in force calculation.
机译:尝试将新药推向市场的平均花费为15亿美元,而这些药的很大一部分在开发的后期阶段被撤回。最近最多有20%的药物停用是由于心脏毒性和心律失常引起的。 3D组织构建体具有更好的生理相关性,因此与常规2D组织相比具有更可靠的毒理学响应。因此,应使用具有人类心脏模型的3D组织特异性毒性筛选,以高通量的方式清除不合格的候选药物。该研究中的平台可实现3D人体心脏组织的批量生产,并可提供准确的力读数,作为毒性评估的关键参考。该平台还结合了电极阵列,以提供逐渐增加的频率的场刺激,这可以使组织显着成熟成婴儿状。整个平台由聚苯乙烯制成,可提供一种惰性药物环境,以消除由聚二甲基硅氧烷(PDMS)引起的药物吸收问题。聚苯乙烯的热压印技术将产生尺寸为5mm x 1mm x 300mm的微孔,该微孔可安装在96孔板的单个孔中。每个微孔将有两根由聚(辛酸八亚甲基马来酸酯(酸酐)柠檬酸酯)制成的自动荧光和柔性导线置于孔的边缘。细胞接种后,心脏组织将紧紧围绕导线并悬挂在孔中。金印刷电极将位于孔的两端,并与电刺激器(Grass88X)连接。光学和荧光高速摄像头将记录设备中组织收缩过程中导线随时间的形状变化。通过跟踪导线的挠度,束挠度方程将用于测量组织产生的收缩力。搏动频率,振幅,收缩和松弛时间也将很容易获得。通过比较计算出的力和使用力传感器测得的力,可以验证设备的精度。该装置可以消除后偏斜设计的共同缺点,在后者中,组织通常会滑落过柱。该设计还将防止不方便地测量立柱上组织的位置,这是力计算中的关键参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号